Search: onr:"swepub:oai:DiVA.org:uu-228237" >
Pirfenidone in Idio...
Pirfenidone in Idiopathic Pulmonary Fibrosis : Expert Panel Discussion on the Management of Drug-Related Adverse Events
-
Costabel, Ulrich (author)
-
Bendstrup, Elisabeth (author)
-
Cottin, Vincent (author)
-
show more...
-
Dewint, Pieter (author)
-
Egan, Jim J. J. (author)
-
Ferguson, James (author)
-
Groves, Richard (author)
-
- Hellström, Per M. (author)
- Uppsala universitet,Gastroenterologi/hepatologi
-
Kreuter, Michael (author)
-
Maher, Toby M. (author)
-
Molina-Molina, Maria (author)
-
- Nordlind, Klas (author)
- Karolinska Institutet
-
Sarafidis, Alexandre (author)
-
Vancheri, Carlo (author)
-
show less...
-
(creator_code:org_t)
- 2014-03-18
- 2014
- English.
-
In: Advances in Therapy. - : Springer Science and Business Media LLC. - 0741-238X .- 1865-8652. ; 31:4, s. 375-391
- Related links:
-
https://uu.diva-port... (primary) (Raw object)
-
show more...
-
https://link.springe...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Pirfenidone is currently the only approved therapy for idiopathic pulmonary fibrosis, following studies demonstrating that treatment reduces the decline in lung function and improves progression-free survival. Although generally well tolerated, a minority of patients discontinue therapy due to gastrointestinal and skin-related adverse events (AEs). This review summarizes recommendations based on existing guidelines, research evidence, and consensus opinions of expert authors, with the aim of providing practicing physicians with the specific clinical information needed to educate the patient and better manage pirfenidone-related AEs with continued pirfenidone treatment. The main recommendations to help prevent and/or mitigate gastrointestinal and skin-related AEs include taking pirfenidone during (or after) a meal, avoiding sun exposure, wearing protective clothing, and applying a broad-spectrum sunscreen with high ultraviolet (UV) A and UVB protection. These measures can help optimize AE management, which is key to maintaining patients on an optimal treatment dose.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Keyword
- Adverse event management
- Expert opinion
- Gastrointestinal events
- Idiopathic pulmonary fibrosis
- Photosensitivity
- Pirfenidone
- Respiratory
- Safety
- Skin-related events
Publication and Content Type
- ref (subject category)
- for (subject category)
Find in a library
To the university's database
- By the author/editor
-
Costabel, Ulrich
-
Bendstrup, Elisa ...
-
Cottin, Vincent
-
Dewint, Pieter
-
Egan, Jim J. J.
-
Ferguson, James
-
show more...
-
Groves, Richard
-
Hellström, Per M ...
-
Kreuter, Michael
-
Maher, Toby M.
-
Molina-Molina, M ...
-
Nordlind, Klas
-
Sarafidis, Alexa ...
-
Vancheri, Carlo
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Pharmacology and ...
- Articles in the publication
-
Advances in Ther ...
- By the university
-
Uppsala University
-
Karolinska Institutet